View from City Road: The benefit of the doubt
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.LIKE the prodigal son, Eagle Star has been forgiven by its parent. After it lost a fortune in the past two-and-a-half years, BAT Industries has prepared a fatted calf in the form of a pounds 190m capital injection.
The deal's structure - in effect a rights issue with BAT the sole shareholder - underlines the attractions of being part of a deep- pocketed conglomerate. Commercial Union and General Accident had to raise money on the open market through preference share issues and Royal Insurance issued a convertible bond last week. The battered composite sector has raised pounds 900m so far in 1992.
BAT's rationale is that the worst of the domestic mortgage indemnity nightmare is over; motor and household insurance rates have hardened and now is the time to go
out and grab some of this profitable business.
But each new premium written reduces Eagle Star's all-important solvency ratio, in turn reducing customers' confidence in its policies. This is where BAT's capital injection in the form of ordinary shares comes in.
It has also capitalised a pounds 260m loan made to Eagle Star earlier in the year, most of which was in turn lent on to BAT's US insurance giant, Farmers.
BAT can easily afford such an investment. It will increase gearing by only 3 percentage points and should not damage earnings if Eagle Star starts paying dividends as anticipated to the parent next year, after a two-year lapse.
But shareholders must wonder whether Eagle Star should be trusted with the money. It has been crucified by UK domestic mortgage indemnity losses amounting to pounds 213m in 1991, and likely to reach another pounds 100m this year.
Combined with losses on commercial mortgage business, Eagle Star has lost pounds 640m in the past two-and-a-half years, equal to the figure BAT paid for it in 1984.
Domestic mortgage indemnity losses are expected to continue at about pounds 25m- pounds 30m per quarter at least until mid 1993.
Newly-appointed Martin Broughton, the managing director of financial services, appears contrite about previous losses. He deserves the benefit of the doubt.
On this basis, the shares, which have outperformed by more than 40 per cent this year, will continue to attract followers.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments